Trial Profile
Pharmacokinetics of Low- Dose Lopinavir/Ritonavir Tablet Formulation HIV-1 Infected Children.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 24 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 03 Feb 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 16 Jun 2010 New trial record